601 related articles for article (PubMed ID: 28614627)
1. A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer.
Solheim TS; Laird BJA; Balstad TR; Stene GB; Bye A; Johns N; Pettersen CH; Fallon M; Fayers P; Fearon K; Kaasa S
J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):778-788. PubMed ID: 28614627
[TBL] [Abstract][Full Text] [Related]
2. A randomized phase II study of nutritional and exercise treatment for elderly patients with advanced non-small cell lung or pancreatic cancer: the NEXTAC-TWO study protocol.
Miura S; Naito T; Mitsunaga S; Omae K; Mori K; Inano T; Yamaguchi T; Tatematsu N; Okayama T; Morikawa A; Mouri T; Tanaka H; Kimura M; Imai H; Mizukami T; Imoto A; Kondoh C; Shiotsu S; Okuyama H; Ueno M; Takahashi T; Tsuji T; Aragane H; Inui A; Higashiguchi T; Takayama K
BMC Cancer; 2019 May; 19(1):528. PubMed ID: 31151425
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of a multimodal intervention on malnutrition in patients with lung cancer during primary anti-neoplastic treatment.
Tobberup R; Carus A; Rasmussen HH; Falkmer UG; Jorgensen MG; Schmidt EB; Jensen NA; Mark EB; Delekta AM; Antoniussen CS; Bøgsted M; Holst M
Clin Nutr; 2021 Feb; 40(2):525-533. PubMed ID: 32600857
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non-small-cell lung cancer.
Naito T; Mitsunaga S; Miura S; Tatematsu N; Inano T; Mouri T; Tsuji T; Higashiguchi T; Inui A; Okayama T; Yamaguchi T; Morikawa A; Mori N; Takahashi T; Strasser F; Omae K; Mori K; Takayama K
J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):73-83. PubMed ID: 30334618
[TBL] [Abstract][Full Text] [Related]
5. Cancer cachexia: rationale for the MENAC (Multimodal-Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial.
Solheim TS; Laird BJA; Balstad TR; Bye A; Stene G; Baracos V; Strasser F; Griffiths G; Maddocks M; Fallon M; Kaasa S; Fearon K
BMJ Support Palliat Care; 2018 Sep; 8(3):258-265. PubMed ID: 29440149
[TBL] [Abstract][Full Text] [Related]
6. Effect of a leucine-rich supplement in combination with nutrition and physical exercise in advanced cancer patients: A randomized controlled intervention trial.
Storck LJ; Ruehlin M; Gaeumann S; Gisi D; Schmocker M; Meffert PJ; Imoberdorf R; Pless M; Ballmer PE
Clin Nutr; 2020 Dec; 39(12):3637-3644. PubMed ID: 32340904
[TBL] [Abstract][Full Text] [Related]
7. Effect of multimodal intervention care on cachexia in patients with advanced cancer compared to conventional management (MIRACLE): an open-label, parallel, randomized, phase 2 trial.
Maeng CH; Kim BH; Chon J; Kang WS; Kang K; Woo M; Hong IK; Lee J; Lee KY
Trials; 2022 Apr; 23(1):281. PubMed ID: 35410294
[TBL] [Abstract][Full Text] [Related]
8. Evidence base for multimodal therapy in cachexia.
Solheim TS; Laird BJ
Curr Opin Support Palliat Care; 2012 Dec; 6(4):424-31. PubMed ID: 23111703
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and efficacy of enteral tube feeding on weight stability, lean body mass, and patient-reported outcomes in pancreatic cancer cachexia.
Gresham G; Placencio-Hickok VR; Lauzon M; Nguyen T; Kim H; Mehta S; Paski S; Pandol SJ; Osipov A; Gong J; Jamil LH; Nissen N; Lo SK; Hendifar AE
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1959-1968. PubMed ID: 34609081
[TBL] [Abstract][Full Text] [Related]
10. A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), resistance training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients--ACCeRT study.
Rogers ES; MacLeod RD; Stewart J; Bird SP; Keogh JW
BMC Cancer; 2011 Nov; 11():493. PubMed ID: 22111896
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy in cachexia.
Del Fabbro E
Ann Palliat Med; 2019 Jan; 8(1):59-66. PubMed ID: 30180745
[TBL] [Abstract][Full Text] [Related]
12. [Research Progress of Pharmacological Therapy and Nutritional Support for Cachexia
in Lung Cancer Patients].
Wang J; Jia W; Li D; Song Y; Sun N; Yang K; Li H; Yin C
Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):420-424. PubMed ID: 35747921
[TBL] [Abstract][Full Text] [Related]
13. Cachexia and pancreatic cancer: are there treatment options?
Mueller TC; Burmeister MA; Bachmann J; Martignoni ME
World J Gastroenterol; 2014 Jul; 20(28):9361-73. PubMed ID: 25071331
[TBL] [Abstract][Full Text] [Related]
14. Power Comparisons and Clinical Meaning of Outcome Measures in Assessing Treatment Effect in Cancer Cachexia: Secondary Analysis From a Randomized Pilot Multimodal Intervention Trial.
Balstad TR; Brunelli C; Pettersen CH; Schønberg SA; Skorpen F; Fallon M; Kaasa S; Bye A; Laird BJA; Stene GB; Solheim TS
Front Nutr; 2020; 7():602775. PubMed ID: 33585533
[No Abstract] [Full Text] [Related]
15. Fish oil supplementation in the treatment of cachexia in pancreatic cancer patients.
Brown TT; Zelnik DL; Dobs AS
Int J Gastrointest Cancer; 2003; 34(2-3):143-50. PubMed ID: 15361649
[TBL] [Abstract][Full Text] [Related]
16. [Cachexia and Sarcopenia Associated with Lung Cancer].
Tanaka S; Takayama K
Gan To Kagaku Ryoho; 2020 Nov; 47(11):1537-1541. PubMed ID: 33268723
[TBL] [Abstract][Full Text] [Related]
17. Practical multimodal care for cancer cachexia.
Maddocks M; Hopkinson J; Conibear J; Reeves A; Shaw C; Fearon KC
Curr Opin Support Palliat Care; 2016 Dec; 10(4):298-305. PubMed ID: 27635765
[TBL] [Abstract][Full Text] [Related]
18. Nutritional counseling and nutritional supplements: a cornerstone of multidisciplinary cancer care for cachectic patients.
Isenring EA; Teleni L
Curr Opin Support Palliat Care; 2013 Dec; 7(4):390-5. PubMed ID: 24189894
[TBL] [Abstract][Full Text] [Related]
19. [Cachexia - A Cluster of Losses].
Christ SM; Blum D
Praxis (Bern 1994); 2021 Nov; 110(15):881-885. PubMed ID: 34814713
[TBL] [Abstract][Full Text] [Related]
20. Dietetic assessment and intervention in lung cancer.
Phillips I; Hug A; Allan L; Ezhil V
Curr Opin Support Palliat Care; 2019 Dec; 13(4):311-315. PubMed ID: 31313701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
